Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
United States Revenue	940.30M	938.50M	Log In	Log In	Log In	Upgrade
Germany Revenue	280.60M	310.70M	Log In	Log In	Log In	Upgrade
Rest of Europe Revenue	940.10M	873.00M	Log In	Log In	Log In	Upgrade
China Revenue	451.00M	471.20M	Log In	Log In	Log In	Upgrade
Rest of Asia Pacific Revenue	564.10M	518.50M	Log In	Log In	Log In	Upgrade
Total Asia Pacific Revenue	1.02B	989.70M	Log In	Log In	Log In	Upgrade
Other Countries Revenue	266.70M	254.50M	Log In	Log In	Log In	Upgrade
Revenue (Total)	3.44B	3.37B	Log In	Log In	Log In	Upgrade

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
BSI BioSpin Revenue	908.50M	905.70M	Log In	Log In	Log In	Upgrade
BSI CALID Revenue	1.17B	1.09B	Log In	Log In	Log In	Upgrade
BSI Life Science Revenue	2.07B	2.00B	Log In	Log In	Log In	Upgrade
BSI Nano Revenue	1.11B	1.10B	Log In	Log In	Log In	Upgrade
Total BSI Revenue	3.19B	3.10B	Log In	Log In	Log In	Upgrade
BEST Revenue	266.40M	283.00M	Log In	Log In	Log In	Upgrade
Eliminations from Revenue	-12.10M	-14.10M	Log In	Log In	Log In	Upgrade
Revenue (Other)	-3.19B	-3.10B	Log In	Log In	Log In	Upgrade
Revenue (Total)	3.44B	3.37B	Log In	Log In	Log In	Upgrade

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
BSI BioSpin Operating Income	131.10M	157.80M	Log In	Log In	Log In	Upgrade
BSI CALID Operating Income	169.80M	180.00M	Log In	Log In	Log In	Upgrade
BSI Life Science Operating Income	300.90M	337.80M	Log In	Log In	Log In	Upgrade
BSI Nano Operating Income	-25.30M	2.30M	Log In	Log In	Log In	Upgrade
Corporate, Eliminations and Other Operating Income	-122.10M	-121.90M	Log In	Log In	Log In	Upgrade
Total BSI Operating Income	153.45M	218.20M	Log In	Log In	Log In	Upgrade
BEST Operating Income	30.40M	34.90M	Log In	Log In	Log In	Upgrade
Operating Income (Other)	-153.45M	-218.20M	Log In	Log In	Log In	Upgrade
Operating Income (Total)	183.90M	253.10M	Log In	Log In	Log In	Upgrade

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
BSI BioSpin Capital Expenditures	-	22.80M	Log In	Log In	Log In	Upgrade
BSI CALID Capital Expenditures	-	34.10M	Log In	Log In	Log In	Upgrade
BSI Life Science Capital Expenditures	-	56.90M	Log In	Log In	Log In	Upgrade
BSI Nano Capital Expenditures	-	19.30M	Log In	Log In	Log In	Upgrade
Corporate Capital Expenditures	-	14.80M	Log In	Log In	Log In	Upgrade
Total BSI Capital Expenditures	-	91.00M	Log In	Log In	Log In	Upgrade
BEST Capital Expenditures	-	24.30M	Log In	Log In	Log In	Upgrade

Updated Aug 4, 2025. Data Source: Fiscal.ai.